Cargando…
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-related malignancies, only cancers of B-cell...
Autores principales: | Turrini, Riccardo, Merlo, Anna, Martorelli, Debora, Faè, Damiana Antonia, Sommaggio, Roberta, Montagner, Isabella Monia, Barbieri, Vito, Marin, Oriano, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414862/ https://www.ncbi.nlm.nih.gov/pubmed/28507812 http://dx.doi.org/10.1080/2162402X.2017.1304338 |
Ejemplares similares
-
Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders
por: Martorelli, Debora, et al.
Publicado: (2012) -
Impact of γ-chain cytokines on EBV-specific T cell cultures
por: Merlo, Anna, et al.
Publicado: (2010) -
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
por: Turrini, Riccardo, et al.
Publicado: (2011) -
The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2020) -
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4(+) T Cells
por: Muraro, Elena, et al.
Publicado: (2017)